- $423.23m
- $146.11m
- $4.66m
UK's PureTech Health falls after Nordic Capital exits deal talks
Brief: Nordic Capital XI Says Does Not Intend To Make Offer For PureTech
Rule 2.8 Announcement
Brief: Puretech Health In Discussions With Nordic Capital For Possible Cash Offer For Co
Statement re Possible Offer
PRTC's Seaport Adds Finance/Operations Exec to BOD
PDMR Notification RSU Vesting
PRTC Presents at Leerink Partners Healthcare Conf
PRTC's Seaport Publishes New Glyph Platform Data
Brief: PureTech Health Expects Topline Data For Phase 3 Restorative303 Study In 2026
PRTC's Vedanta Publishes Ph2 in Nature Medicine
Brief: PureTech Health Says PRTC's LYT-200 Gets Fast Track Designation In AML
Prtc's Lyt: 200 Gets Fast Track Designation in AML
PureTech to Present at the JP Morgan Conference
Brief: PureTech Appoints UBS As UK Corporate Broker
PureTech Appoints UBS as UK Corporate Broker
UK's PureTech Health gains as lung drug meets main goal of mid-stage trial
Brief: Puretech Says Deupirfenidone Slowed Lung Function Decline In IPF Patients
Holding(s) in Company